Metraipolis › archive › dc_e405c554e065

Combination therapy of sutimlimab and rituximab can lead to stable remission in autoimmune hemolytic anemia: a case series — Europe PMC PMID:42616150

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42616150
DOI
10.1007/s00277-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-10-08T03:26:19.500Z
SHA-256 of the archived text
8f77b50dc91f45cc19cba660bcdf5e44ac8af6affaa656492b4315441f37b8fb
Stable URL of this page
https://metraipolis.com/documento/dc_e405c554e065

How to cite

Combination therapy of sutimlimab and rituximab can lead to stable remission in autoimmune hemolytic anemia: a case series — Europe PMC PMID:42616150 — Europe PMC (en), https://europepmc.org/article/MED/42616150 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e405c554e065 (Metraipolis archive dc_e405c554e065, sha256 8f77b50dc91f45cc19cba660bcdf5e44ac8af6affaa656492b4315441f37b8fb)
BibTeX
@misc{dce405c554e065,
  title = {Combination therapy of sutimlimab and rituximab can lead to stable remission in autoimmune hemolytic anemia: a case series — Europe PMC PMID:42616150},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42616150},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e405c554e065; sha256 8f77b50dc91f45cc19cba660bcdf5e44ac8af6affaa656492b4315441f37b8fb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42616150. Agents can read the archived copy with the MCP tool read_document.